Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2010

Open Access 01-12-2010 | Research

CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers

Authors: Yu L Jiang, Na Meng, Jun J Wang, Ping Jiang, Hui SH Yuan, Chen Liu, Ang Qu, Rui J Yang

Published in: Radiation Oncology | Issue 1/2010

Login to get access

Abstract

Background

To investigate the feasibility, and safety of 125I seed permanent implantation for recurrent head and neck carcinoma under CT-guidance.

Results

A retrospective study on 14 patients with recurrent head and neck cancers undergone 125I seed implantation with different seed activities. The post-plan showed that the actuarial D90 of 125I seeds ranged from 90 to 218 Gy (median, 157.5 Gy). The follow-up was 3 to 60 months (median, 13 months). The median local control was 18 months (95% CI, 6.1-29.9 months), and the 1-, 2-, 3-, and 5- year local controls were 52%, 39%, 39%, and 39%, respectively. The 1-, 2-, 3-, and 5- survival rates were 65%, 39%, 39% and 39%, respectively, with a median survival time of 20 months (95% CI, 8.7-31.3 months). Of all patients, 28.6% (4/14) died of local recurrence, 7.1% (1/14) died of metastases, one patient died of hepatocirrhosis, and 8 patients are still alive to the date of data analysis.

Conclusion

CT-guided 125I seed implantation is feasible and safe as a salvage or palliative treatment for patients with recurrent head and neck cancers.
Appendix
Available only for authorised users
Literature
1.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer Statistics, 2006. CA Cancer J Clin. 2006, 56: 106-130. 10.3322/canjclin.56.2.106.CrossRefPubMed
2.
Marcial VA, Pajak TF, Kramer S, Yupchong L, Stetz J: Radiation Oncology Group (RTOG) studies in head and neck cancer. Semin Oncol. 1998, 15: 39-60.
3.
Ridge JA: Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence. Semin Oncol. 1993, 20: 419-429.PubMed
4.
Wang CC: Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987, 13: 953-956. 10.1016/0360-3016(87)90030-7.CrossRefPubMed
5.
Harrison LB: Application of brachytherapy in head and neck cancer. Semi Surg Oncol. 1997, 13: 177-184. 10.1002/(SICI)1098-2388(199705/06)13:3<177::AID-SSU4>3.0.CO;2-4.CrossRef
6.
Goffinet D, Fee WE, Wells J, Austin-Seymour M, Clarke D, Mariscal JM: 192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of bare tongue carcinoma by radiation therapy. Cancer. 1985, 55: 941-948. 10.1002/1097-0142(19850301)55:5<941::AID-CNCR2820550505>3.0.CO;2-G.CrossRefPubMed
7.
Hilaris BS, Lewis JS, Henschke MK: Therapy of recurrent cancer of the nasopharynx. Arch Otolaryngol. 1968, 87: 506-510.CrossRefPubMed
8.
Wang CC, Burse K, Gitterman M: A simple afterloading applicator or intracavitary irradiation of carcinoma of the nasopharynx. Radiology. 1975, 115: 737-738.CrossRefPubMed
9.
Ash D: Interstitial therapy. Acta Radiol. 1986, 16: 369-393.
10.
Syed AMN, Puthawala A: Afterloading interstitial implants in head and neck cancer. Arch Otolaryngol. 1980, 106: 541-546.CrossRef
11.
Lee DJ, Liberman FZ, Park RI, Zinreich ES: Intraoperative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology. 1991, 178: 879-882.CrossRefPubMed
12.
Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G: CT-guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver malignancies. Strahlenther Onkol. 2004, 180: 274-280. 10.1007/s00066-004-1179-4.CrossRefPubMed
13.
Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Seidensticker M, Wieners G, Spors B, Werk M, Rosner C: CT-guided brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys. 2004, 58: 1496-1505. 10.1016/j.ijrobp.2003.09.024.CrossRefPubMed
14.
Jun JW, Hui ShuY, Ji NL, Wei JJ, Yu LJ, Su QT: Interstitial permanent implantation of 125I seeds as salvage therapy for re-recurrent rectal carcinoma. Int J Colorectum Dis. 2009, 24: 391-399. 10.1007/s00384-008-0628-4.CrossRef
15.
Jun JW, Hui ShuY, Qing JM, Xiao GL, Hao W, Yu LJ, Su QT, Rui JY: Interstitial 125I seeds implantation to treat spinal metastatic and primary paraspinal malignancies. Med Oncol. 2009, 10.1007/s12032-009-9212-1
16.
Cox JD, Stetz J, Pajak TF: The toxicity criteria of the Radiation Therapy Oncology for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995, 31: 1341-1346. 10.1016/0360-3016(95)00060-C.CrossRefPubMed
17.
Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer. 1981, 47: 207-214. 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6.CrossRefPubMed
18.
Emami B, Bignardi M, Devineni VR, Spector GJ, Hederman MA: Re-irradiation of head and neck cancer. Laryngoscope. 1987, 97: 85-88. 10.1288/00005537-198701000-00016.CrossRefPubMed
19.
Kennedy JT, Krause CJ, Loevy S: The importance of tumor attachment to the carotid artery. Arch Otolaryngol Head Neck Surg. 1977, 103: 70-73.CrossRef
20.
Langois D, Eschwege F, Kramer A, Richard JM: Re-irradiation of head and neck cancers. Radiother Oncol. 1985, 3: 27-33. 10.1016/S0167-8140(85)80006-2.CrossRef
21.
Pomp J, Levendage PC, van Putten WLJ: Re-irradiation with recurrent tumors in the head and neck. Am J Clin Oncol. 1988, 11: 543-549. 10.1097/00000421-198810000-00007.CrossRefPubMed
22.
Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Spanos W, Rotman M: RTOG 96-10: Re-irradiation with concurrent hydroxyurea and 5-flurouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001, 51: 1299-1304. 10.1016/S0360-3016(01)01745-X.CrossRefPubMed
23.
Stevens KR, Britsch A, Moss WT: High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys. 1994, 29: 687-698. 10.1016/0360-3016(94)90555-X.CrossRefPubMed
24.
Emami B, Marks JE: Re-irradiation of recurrent carcinoma of the head and neck by afterloading interstitial 192Ir implant. Laryngoscope. 1983, 93: 1345-1347.PubMed
25.
Mazeron JJ, Langlolis D, Glaubinger D, Huart J, Martin M, Raynal M, Calitchi E, Ganem G: Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys. 1987, 13: 957-962. 10.1016/0360-3016(87)90031-9.CrossRefPubMed
26.
Puthawala AA, Syed AMN: Interstitial re-irradiation for recurrent and/or persistent head and neck cancers. Int J Radiat Oncol Biol Phys. 1987, 13: 1113-1114. 10.1016/0360-3016(87)90052-6.CrossRefPubMed
27.
Geiger M, Strnad V, Lotter M, Sauer R: Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and -neck cancer. Brachytherapy. 2002, 1: 149-153. 10.1016/S1538-4721(02)00056-9.CrossRefPubMed
28.
Strnad V, Geiger M, Lotter M, Sauer R: The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy. 2003, 2: 158-163. 10.1016/S1538-4721(03)00132-6.CrossRefPubMed
29.
Senan S, Levendage PC: Brachytherapy for recurrent head and neck cancer. Hematol Oncol Clin North Am. 1999, 13: 531-542. 10.1016/S0889-8588(05)70073-3.CrossRefPubMed
30.
Decroix Y, Ghossein NA: Experience of the Curie Institute in treatment of cancer of the mobile tongue. Cancer. 1981, 47: 496-502. 10.1002/1097-0142(19810201)47:3<496::AID-CNCR2820470312>3.0.CO;2-Q.CrossRefPubMed
31.
Gilbert EH, Goffinet DR, Ragshaw WA: Carcinoma of the oral tongue and floor of mouth: Fifteen years experience with linear accelerator therapy. Cancer. 1975, 35: 1517-1524. 10.1002/1097-0142(197506)35:6<1517::AID-CNCR2820350607>3.0.CO;2-3.CrossRefPubMed
32.
Shasha D, Harrison LB, Chiu-Tsao ST: The role of brachytherapy in head and neck cancer. Semin Radiat Oncol. 1998, 8: 270-281. 10.1016/S1053-4296(98)80025-8.CrossRefPubMed
33.
Fee WE, Goffinet DR, Paryani S, Goode RL, Levine PA, Hopp ML: Intraoperative Iodine-125 implants. Arch Otolaryngol. 1983, 109: 727-730.CrossRefPubMed
34.
Vikram B, Hilaris BS, Anderson L, Strong EW: Permanent iodine-125 implants in head and neck cancer. Cancer. 1983, 51: 1310-1314. 10.1002/1097-0142(19830401)51:7<1310::AID-CNCR2820510722>3.0.CO;2-I.CrossRefPubMed
35.
Goffinet DR, Martinez A, Fee WE: I-125 vicry suture implants as a surgical adjuvant in cancer of the head and neck. Int J Radiat Oncol Biol Phys. 1985, 11: 399-402. 10.1016/0360-3016(85)90164-6.CrossRefPubMed
36.
Park RI, Liberman FZ, Lee DJ, Goldsmith MM, Price J: Iodine-125 seed implantation as an adjuvant to surgery in advanced recurrent squamous cell cancer of the head and neck. Laryngoscope. 1991, 101: 405-410. 10.1288/00005537-199104000-00012.CrossRefPubMed
37.
Martinez A, Goffinet DR, Fee W, Goode R, Cox RS: Iodine-125 implants as an adjuvant to surgery and external beam radiotherapy in the management of locally advanced head and neck cancer. Cancer. 1983, 51: 973-979. 10.1002/1097-0142(19830315)51:6<973::AID-CNCR2820510602>3.0.CO;2-T.CrossRefPubMed
38.
Ricke J, Wust P, Wieners G, Hengst S, Pech M, Hanninen EL, Felix R: CT-guided interstitial single fraction HDR brachytherapy of lung tumors: Phase I results of a novel technique. Chest. 2005, 127: 2237-2242. 10.1378/chest.127.6.2237.CrossRefPubMed
39.
Krempien RC, Grehn C, Haag C, Straulino A, Hensley EW, Kotrikova B, Hofele Ch, Debus J, Harms W: Feasibility report for retreatment of locally recurrent head-and neck cancers by combined brachytherapy using frameless image-guided 3 D interstitial brachytherapy. Brachytherapy. 2005, 4: 154-162. 10.1016/j.brachy.2005.02.001.CrossRefPubMed
40.
Harms W, Krempien R, Grehn C, Hensley F, Debus J, Becker HD: Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumors. Strahlenther Onkol. 2006, 182: 108-111. 10.1007/s00066-006-1503-2.CrossRefPubMed
41.
Griffin PC, Amin PA, Hughes P, Levine AM, Sewchand WW, Salazar OM: Pelvic mass: CT-guided interstitial catheter implantation with high-dose-rate remote afterloader. Radiology. 1994, 191: 581-583.CrossRefPubMed
42.
Kolotas C, Baltas D, Zamboglu N: CT-based interstitial HDR brachytherapy. Strahlenther Onkol. 1999, 175: 419-427. 10.1007/s000660050031.CrossRefPubMed
Metadata
Title
CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers
Authors
Yu L Jiang
Na Meng
Jun J Wang
Ping Jiang
Hui SH Yuan
Chen Liu
Ang Qu
Rui J Yang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2010
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-5-68

Other articles of this Issue 1/2010

Radiation Oncology 1/2010 Go to the issue

Research

18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck Cancer: a correlation study between suitable uptake value threshold and tumor parameters

Research

MicroRNA expression after ionizing radiation in human endothelial cells

Methodology

Fractionated stereotactic radiotherapy for skull base tumors: analysis of treatment accuracy using a stereotactic mask fixation system

Research

Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro

Research

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors – a single institution case series and a short review of the literature

Short report

Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma